t(10;10)(q25;q26) FGFR2::SHTN1
Oncogenic mechanisms
Constitutive activation of FGFR2 tyrosine kinase activity
Targeted therapy
Erdafitinib
infigratinib
pemigatinib
Tumor type
Cholangiocarcinoma
non–Small Cell Lung Cancer
Highly cited references
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 34363682 | 2021 | Polymorphous Low-Grade Neuroepithelial Tumor of the Young (PLNTY): Molecular Profiling Confirms Frequent MAPK Pathway Activation. | 45 |
| 39936351 | 2025 | Genomic Differences in Thyroid Cancers From Primary Sites Versus Distant Metastases in Individual Patients: A Clinical Perspective and Preliminary Report. | 0 |
